Effect of albumin administration on outcomes in hypoalbuminemic patients hospitalized with community-acquired pneumonia (ALBUCAP): a prospective, randomized, phase III clinical controlled trial—a trial protocol

Effect of albumin administration on outcomes in hypoalbuminemic patients hospitalized with community-acquired pneumonia (ALBUCAP): a prospective, randomized, phase III clinical controlled trial—a trial protocol

Abstract Background Community-acquired pneumonia (CAP) remains a leading cause of death worldwide, and hypoalbuminemia is associated with worse outcomes. However, it remains uncertain whether albumin administration could have any beneficial effects. We aim to assess whether the administration of alb...

Full description

Bibliographic Details
Main Authors: Alexander Rombauts, Gabriela Abelenda-Alonso, Antonella Francesca Simonetti, Guillermo Verdejo, Yolanda Meije, Lucia Ortega, Mercedes Clemente, Jordi Niubó, Yolanda Ruiz, Carlota Gudiol, Cristian Tebé, Sebastian Videla, Jordi Carratalà
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Trials
Subjects:
Community-acquired pneumonia
Albumin
Inflammation
Randomized controlled trial
Online Access:http://link.springer.com/article/10.1186/s13063-020-04627-1

Internet

http://link.springer.com/article/10.1186/s13063-020-04627-1

Similar Items